Morris Gabriel S 4
4 · Immix Biopharma, Inc. · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Morris Gabriel S
DirectorCFO
Transactions
- Exercise of In-Money
Common Stock
2025-12-08$0.80/sh+156,000$124,800→ 426,844 total(indirect: See footnote) - Purchase
Common Stock
2025-12-10$6.58/sh+770$5,067→ 291,429 total - Exercise of In-Money
Warrants (right to purchase)
2025-12-08−96,000→ 0 total(indirect: See footnote)Exercise: $0.80From: 2021-03-18Exp: 2031-03-18→ Common stock (96,000 underlying) - Exercise of In-Money
Warrants (right to purchase)
2025-12-08−60,000→ 0 total(indirect: See footnote)Exercise: $0.80From: 2021-04-02Exp: 2031-04-02→ Common stock (60,000 underlying)
Holdings
- 24,141(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
- [F2]Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.
- [F3]The warrants were held by Alwaysraise LLC.